Does the use of the Venner™ PneuX YP™ VAP prevention system reduce the risk of Ventilator Associated Pneumonia (VAP) following major heart surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN45757289

Enrollment

240

Registered

2011-03-22

Start date

2011-01-17

Completion date

Unknown

Last updated

2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Cardiovascular, Infection, Respiratory, Generic Health Relevance and Cross Cutting Themes

Interventions

Endotracheal intubation, Standard endotracheal tube VS Venner Pneux YP VAP Preventon system tube

Study Entry : Single Randomisation only

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male and female patients = 70 years scheduled for elective major heart surgery 2. Patients = 16 years with impaired left ventricular function scheduled for elective major heart surgery. Impaired left ventricular function is defined as left ventricular ejection fraction =49% Target Gender: Male & Female ; Lower Age Limit 16 years

Exclusion criteria

Exclusion criteria: 1. Patients under 16 years old 2. Patients who present as an emergency for major heart surgery 3. Patients in whom pneumonia is proven or suspected prior to surgery 4. Pregnant patients 5. Patients enrolled in another study 6. Patients who are unable to give written consent

Design outcomes

Primary

Measure	Time frame
Proportion of patients who develop VAP between the two groups; Timepoint(s): Within 48 hours of extubation	—

Secondary

Measure	Time frame
Not provided at the time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026